Seventy five patients with severely bleeding peptic ulcer were included in a controlled comparative trial to assess the efficacy and safety of endoscopic injection therapy in preventing rebleeding from peptic ulcers that presented at endoscopy with a protruding vessel. Twenty five patients were treated with injection of epinephrine followed by polidocanol, 25 were treated with injection ofabsolute alcohol, and 25 with sham injection. Rebleeding occurred in 44% of patients in the sham group, 40% of those treated with epinephrine and polidocanol, and in 20% of those treated with absolute ethanol. The difference in the haemostasis rate between the control and ethanol treated subjects nearly reached significance (p=0.07). A second therapy session resulted in haemostasis rates of 68% in the epinephrine-polidocanol group and of 88% in the absolute ethanol group. These rates after two treatments as well as the emergency surgery rates (32% in the epinephrine-polidocanol group and 8% in the absolute ethanol group; p=007) were not significantly different. In eight of the 11 patients with rebleeding in the sham treatment group, definitive haemostasis was achieved by elective injection therapy. Overall transfusion requirements were mean (SD) 6*0 (0.7) units in the sham group, 6-0 (0.9) in the epinephrinepolidocanol group, and 3 9 (0 5) in the absolute ethanol group. Only the difference between ethanol and sham was significant (p=002). This study shows that injection with absolute ethanol reduces rebleeding in these patients and significantly lowers transfusion requirements. Absolute ethanol was superior to epinephrine-polidocanol, which was not significantly better than sham therapy.
Injection therapy for bleeding peptic ulcer is attractive because it is both simple and cheap. Various solutions are used for injection, including epinephrine 1:10 000, polidocanol 1%, absolute ethanol, 5% ethanolamine, and thrombin. In addition, the injected volumes are not standardised.
Sham-controlled trials using epinephrine injection,' epinephrine-polidocanol injection, ethanol injection,5 and epinephrine-ethanolamineh 7 have shown the benefit of endoscopic injection in preventing continued or recurrent bleeding from peptic ulcers and thereby avoiding emergency surgery. The ideal solution for injection, however, has yet to be defined, how- NSAIDs=non-steroidal anti-inflammatory drugs. Chung et al,'6 in a prospective randomised trial, compared the efficacy of endoscopic epinephrine injection and heater probe in actively bleeding peptic ulcers. Bleeding was initially better controlled with epinephrine injection (96%) than with heater probe (83%; p<O 05) but the outcome was similar in both groups. In the heater probe group there were two perforations.
In a randomised controlled trial'7 comparing absolute alcohol injection with heater probe for the treatment of bleeding and non-bleeding vessels from peptic ulcers, Lin et al found the heater probe to be more effective than injection. In this trial emergency surgery rates and mortality were lowered by both techniques compared with control subjects.
The present study confirms that injection therapy is safe, although isolated cases of gastric wall necrosis"x '9 and even mortality because of injection have been reported."' It is concluded that repeated absolute ethanol injection is an effective way of achieving endoscopic haemostasis. Absolute ethanol seems more effective than epinephrine-polidocanol.
